Cargando…
Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma
Autores principales: | Okuma, Yusuke, Hosomi, Yukio, Miyamoto, Shingo, Shibuya, Masahiko, Okamura, Tatsuru, Hishima, Tsunekazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833961/ https://www.ncbi.nlm.nih.gov/pubmed/27084341 http://dx.doi.org/10.1186/s12885-016-2309-y |
Ejemplares similares
-
Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma
por: Okuma, Yusuke, et al.
Publicado: (2016) -
Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center
por: Okuma, Yusuke, et al.
Publicado: (2014) -
Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma
por: NAGAMATA, MAKOTO, et al.
Publicado: (2014) -
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
por: Kashima, Jumpei, et al.
Publicado: (2016) -
Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis
por: Fukuda, Akito, et al.
Publicado: (2022)